TY - JOUR
T1 - The role of calcium/calmodulin-dependent protein kinase cascade on MIP-1α gene expression of ATL cells
AU - Matsumoto, Kensuke
AU - Murao, Koji
AU - Imachi, Hitomi
AU - Nishiuchi, Takamasa
AU - Cao, Wenming
AU - Yu, Xiao
AU - Li, Junhua
AU - Ahmed, Rania A.M.
AU - Iwama, Hisakazu
AU - Kobayashi, Ryoji
AU - Tokumitsu, Hiroshi
AU - Ishida, Toshihiko
PY - 2008/4
Y1 - 2008/4
N2 - Objective: Adult T-cell leukemia (ATL) is a mature CD4+ T-cell malignancy caused by infection with human T-lymphotrophic virus type-1 and is associated with a marked hypercalcemia in many patients. Recently, it has been proposed that macrophage inflammatory protein-1α (MIP-1α) is the clinical hallmark of hypercalcemia in ATL. In this study, we investigated the effect of extracellular calcium on MIP-1α secretion in ATL cells and the role of Ca2+/calmodulin (CaM)-dependent protein kinase (CaM-K) cascade in transcriptional activation of MIP-1α. Materials and Methods: MIP-1α protein levels in the culture supernatant collected from ATL cells were measured by enzyme-linked immunosorbent assay. Reporter plasmid containing the MIP-1α promoter was transfected to ATL cells, and the promoter activity was measured by luciferase assay. Results: The addition of calcium to the culture medium enhanced the secretion of MIP-1α from ATL cells, which was inhibited by the CaM-KK inhibitor. The transfection of CaM-KIV stimulated MIP-1α promoter activity, and the upstream kinase CaM-KK enhanced the stimulatory effect of CaM-KIV on the promoter activity. Mutation in the cyclic adenosine 5′ monophosphate response element (CRE) within the MIP-1α promoter significantly reduced the effect of CaM-KIV, and CRE mutant promoter activity was not significantly enhanced by the addition of calcium to the culture medium as compared to wild-type promoter activity. Conclusion: Hypercalcemia enhances MIP-1α secretion in ATL cells, and this mechanism requires the involvement of CaM-KK/CaM-KIV cascade through the CRE. These findings raise a possibility that the inhibitory effect of CaM-KK/CaM-KIV cascade may be a potential therapeutic target for ATL.
AB - Objective: Adult T-cell leukemia (ATL) is a mature CD4+ T-cell malignancy caused by infection with human T-lymphotrophic virus type-1 and is associated with a marked hypercalcemia in many patients. Recently, it has been proposed that macrophage inflammatory protein-1α (MIP-1α) is the clinical hallmark of hypercalcemia in ATL. In this study, we investigated the effect of extracellular calcium on MIP-1α secretion in ATL cells and the role of Ca2+/calmodulin (CaM)-dependent protein kinase (CaM-K) cascade in transcriptional activation of MIP-1α. Materials and Methods: MIP-1α protein levels in the culture supernatant collected from ATL cells were measured by enzyme-linked immunosorbent assay. Reporter plasmid containing the MIP-1α promoter was transfected to ATL cells, and the promoter activity was measured by luciferase assay. Results: The addition of calcium to the culture medium enhanced the secretion of MIP-1α from ATL cells, which was inhibited by the CaM-KK inhibitor. The transfection of CaM-KIV stimulated MIP-1α promoter activity, and the upstream kinase CaM-KK enhanced the stimulatory effect of CaM-KIV on the promoter activity. Mutation in the cyclic adenosine 5′ monophosphate response element (CRE) within the MIP-1α promoter significantly reduced the effect of CaM-KIV, and CRE mutant promoter activity was not significantly enhanced by the addition of calcium to the culture medium as compared to wild-type promoter activity. Conclusion: Hypercalcemia enhances MIP-1α secretion in ATL cells, and this mechanism requires the involvement of CaM-KK/CaM-KIV cascade through the CRE. These findings raise a possibility that the inhibitory effect of CaM-KK/CaM-KIV cascade may be a potential therapeutic target for ATL.
UR - http://www.scopus.com/inward/record.url?scp=40649099537&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=40649099537&partnerID=8YFLogxK
U2 - 10.1016/j.exphem.2007.11.013
DO - 10.1016/j.exphem.2007.11.013
M3 - Article
C2 - 18249060
AN - SCOPUS:40649099537
SN - 0301-472X
VL - 36
SP - 390
EP - 400
JO - Experimental Hematology
JF - Experimental Hematology
IS - 4
ER -